Lando & Anastasi, LLP
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
The present invention concerns methods and reagents useful in modulating gene expression in a variety of applications, including use in therapeutic, diagnostic, target validation, and genomic discovery applications. Specifically, the invention relates to synthetic chemically modified small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules capable of mediating RNA interference (RNAi) against target nucleic acid sequences. The small nucleic acid molecules are useful in the treatment of any disease or condition that responds to modulation of gene expression or activity in a cell, tissue, or organism.
Sirna Therapeutics, Inc.
C A C A C A C C C A Y C C C C C
C12N A61K C12N A61K C12N A61K C12N C12N C12N A61K Y02A C07F C12N C12N C12N C12N
additional inventional additional inventional additional inventional additional additional additional additional additional inventional inventional additional additional additional
Leonid Shawn Peter Bharat Pamela Kathy Narendra K Nassim Tongqian David James Chandra Weimin Dennis James Sharon F
Beigelman Zinnen Haeberli Chowrira Pavco Fosnaugh Vaish Usman Chen Morrissey McSwiggen Vargeese Wang Macejak Thompson Jamison